Resilient Q1 from Office Depot; adopts poison pill

Office Depot Inc has reported a strong set of first quarter results, including same-store growth in its retail operations as demand for COVID-19-related products surged.


To continue reading this article, you must have a paid membership.

Join now from just £5

Existing paying members, please log in to access the full story.


If you are not a paying member, sign up now: